AVTR
Avantor Inc
NYSE: AVTR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$8.10
+3.18% today
Updated 2026-04-30
Market cap
$5.35B
P/E ratio
—
P/S ratio
0.82x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$7 – $16
Volume
9.5M
Avantor Inc (AVTR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $1.14B | $10.45B | $9.91B | $9.77B | $9.91B | $13.90B | $13.46B | $12.97B | $12.11B | $11.79B |
| Cash & equivalents | — | $62.90M | $185.40M | $184.70M | $186.70M | $286.60M | $301.70M | $372.90M | $262.90M | $261.90M | $365.40M |
| Current assets | — | $292.00M | $1.83B | $1.90B | $2.02B | $2.23B | $2.48B | $2.66B | $2.38B | $2.15B | $2.45B |
| Total liabilities | — | $1.65B | $13.07B | $12.96B | $7.31B | $7.23B | $9.70B | $8.61B | $7.72B | $6.16B | $6.23B |
| Current liabilities | — | $135.90M | $1.10B | $1.10B | $1.07B | $1.24B | $1.45B | $1.66B | $1.48B | $2.01B | $1.38B |
| Long-term debt | — | $1.28B | $7.01B | $6.78B | $5.02B | $4.87B | $6.98B | $5.92B | $5.28B | $3.23B | $3.92B |
| Shareholder equity | — | $-374.90M | $-2.62B | $-3.05B | $2.46B | $2.67B | $4.20B | $4.86B | $5.25B | $5.96B | $5.57B |
| Retained earnings | — | $-5.70M | $-156.30M | $-238.40M | $-203.70M | $-88.70M | $483.90M | $1.17B | $1.49B | $2.20B | $1.67B |
| Accounts receivable | — | $87.90M | $875.00M | $931.20M | $988.80M | $1.11B | $1.22B | $1.22B | $1.15B | $1.03B | $1.07B |
| Inventory | — | $122.20M | $695.10M | $671.10M | $711.20M | $739.60M | $872.00M | $913.50M | $828.10M | $731.50M | $818.20M |
| Goodwill | — | $186.10M | $2.85B | $2.78B | $2.77B | $2.86B | $5.34B | $5.65B | $5.72B | $5.54B | $4.99B |